Join
Live feed
·
PRReleasevia Quantisnow
NeoGenomics Inc. logo

NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021

ByQuantisnow·Wall Street's wire, on your screen.
NEO· NeoGenomics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NEO (NeoGenomics Inc.) and more on Quantisnow.